Work

Phase I study of a CD19-directed CAR-T cell therapy for Relapsed/refractory mantle cell lymphomas(MCL)

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417006882
Cites:
Cited by:
Related to: